DJ JD Health's Risk-Reward Ratio Looks Appealing -- Market Talk
0219 GMT - JD Health International's risk-reward ratio seems attractive, as the share price has plunged in recent months, Daiwa Capital says. It upgrades the stock to outperform from hold and lowers the target price to HK$130.50 from HK$148.20. The investment bank raises its 2021-22 revenue forecast for the company by 5%-7% as it expects JD Health to record fast user-traffic growth, thanks to the strength of its digital marketing segment, which posted triple-digit growth in 2020. JD Health's consistent track record in online healthcare services and its supply-chain infrastructure could be profit-growth drivers, Daiwa adds. Shares are down 7.2% at HK$109.90 amid a broader selloff in Hong Kong tech shares. (yiwei.wong@wsj.com)
(END) Dow Jones Newswires
May 23, 2021 22:19 ET (02:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.